Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bendo Biotech is a clinical-stage biopharmaceutical company headquartered in Shanghai, China, specializing in the development of mRNA-based vaccines and therapeutics. The company has developed a proprietary mRNA technology platform that integrates sequence optimization, modified nucleoside technology, and lipid nanoparticle (LNP) delivery systems. Its lead program, BD-mRNA01, is an mRNA vaccine for COVID-19 that has progressed into clinical trials. Beyond infectious diseases, Bendo Biotech is expanding its pipeline to include oncology vaccines and protein replacement therapies. The company is supported by leading venture capital investors and aims to provide innovative, high-quality mRNA medicines for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 本道生物科技.